Medtronic Announces Global Launch of Miniature Cardiac Monitor, Reveal LINQ™ ICM

Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance, CE (Conformité Européenne) Mark, and the global launch of its Reveal LINQ Insertable Cardiac Monitor (ICM) System, the smallest implantable cardiac monitoring device available for patients.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news